Sign In
Buy KURA
$8.66
-0.315 (-3.51%)
At Close: Jun 03, 2026
The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche's Cancer Drug Flunks Study
12:43pm, Friday, 24'th Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 23) Baudax Bio Inc (NASDAQ: BXRX ) Mesoblast limited (
Kura Oncology Inc (NASDAQ:KURA) Given Average Recommendation of "Buy" by Brokerages
06:36am, Friday, 24'th Jan 2020
Kura Oncology Inc (NASDAQ:KURA) has received a consensus recommendation of “Buy” from the eleven brokerages that are currently covering the firm, Marketbeat.com reports. Two investment analysts ha
Kura Oncology Chief Medical Officer Plans to Step Down Next Month
01:01am, Friday, 24'th Jan 2020
Kura Oncology (NASDAQ: ]) announced Thursday that its chief medical officer, Antonio Gualberto, would step down on Feb. 7 "to pursue other opportunities."
Kura Oncology Announces Transition of Chief Medical Officer
09:05pm, Thursday, 23'rd Jan 2020
– Dr. Antonio Gualberto to step down after enabling multiple registrational strategies for tipifarnib, positioning program for success – – Clinical development, regulatory and.
Kura Oncology Announces Transition ofChief Medical Officer
09:05pm, Thursday, 23'rd Jan 2020
– Dr. Antonio Gualberto to step down after enabling multiple registrational strategies for tipifarnib, positioning program for success – – Clinical...
Kura Oncology (NASDAQ:KURA) Hits New 1-Year Low at $12.65
08:54am, Thursday, 23'rd Jan 2020
Kura Oncology Inc (NASDAQ:KURA)’s share price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $12.65 and last traded at $12.70, with a volume of 24528 shares. Th
The Daily Biotech Pulse: Johnson & Johnson Earnings, FDA Nod For Horizon Therapeutics, Slew Of Secondary Offerings
01:25pm, Wednesday, 22'nd Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 21) Abbott Laboratories (NYSE: ABT ) Apellis Pharmaceu
3 Healthcare Stocks That Can Double in the Next Year
09:09am, Tuesday, 21'st Jan 2020
Risk and reward are two of the most commonly used words in investing. The two are symbiotic and complement each other perfectly. Where there is more risk, the reward is likely to be more abundant. Of
-$0.42 EPS Expected for Kura Oncology Inc (NASDAQ:KURA) This Quarter
11:54am, Monday, 20'th Jan 2020
Equities analysts expect that Kura Oncology Inc (NASDAQ:KURA) will post earnings per share of ($0.42) for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for
DUBLIN--(BUSINESS WIRE)--The "Mitogen Activated Protein Kinase 1 - Pipeline Review, H2 2019" drug pipelines have been added to ResearchAndMarkets.com's offering. Summary According to the recently publ
Kura Oncology (NASDAQ:KURA) Downgraded by BidaskClub to Strong Sell
06:30am, Saturday, 18'th Jan 2020
Kura Oncology (NASDAQ:KURA) was downgraded by stock analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a report issued on Saturday, BidAskClub reports. KURA has been the
Kura Oncology to Present at J.P. Morgan Healthcare Conference
12:30pm, Thursday, 09'th Jan 2020
Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of cancer, today announced its participation at the 38th Annu
Kura Oncology Appoints Kirsten Flowers as Chief Commercial Officer
12:30pm, Monday, 06'th Jan 2020
Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of cancer, today announced the appointment of Kirsten Flowers
Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of cancer, today announced that the U.S. Food and Drug Admini
Kura Oncology, Inc. (KURA): Hedge Funds Can’t Make Up Their Minds
07:21pm, Tuesday, 10'th Dec 2019
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks a
